PubMed:12373350 / 371-526 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCoin-PubTator-for-Tuning

    {"project":"LitCoin-PubTator-for-Tuning","denotations":[{"id":"26","span":{"begin":0,"end":15},"obj":"DiseaseOrPhenotypicFeature"},{"id":"27","span":{"begin":133,"end":146},"obj":"ChemicalEntity"}],"attributes":[{"id":"A26","pred":"tao:has_database_id","subj":"26","obj":"MESH:D006333"},{"id":"A27","pred":"tao:has_database_id","subj":"27","obj":"MESH:D018943"}],"text":"Cardiac failure occurred progressively after 31-month, 32-month, and 14-month intervals, respectively, following completion of first anthracycline therapy."}

    LitCoin-Disease-Tuning-1

    {"project":"LitCoin-Disease-Tuning-1","denotations":[{"id":"T10","span":{"begin":0,"end":15},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A10","pred":"ID:","subj":"T10","obj":"D006333"}],"text":"Cardiac failure occurred progressively after 31-month, 32-month, and 14-month intervals, respectively, following completion of first anthracycline therapy."}

    LitEisuke

    {"project":"LitEisuke","denotations":[{"id":"T8","span":{"begin":0,"end":15},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A8","pred":"#label","subj":"T8","obj":"D006333"}],"text":"Cardiac failure occurred progressively after 31-month, 32-month, and 14-month intervals, respectively, following completion of first anthracycline therapy."}

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T4","span":{"begin":0,"end":155},"obj":"Sentence"},{"id":"T4","span":{"begin":0,"end":155},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Cardiac failure occurred progressively after 31-month, 32-month, and 14-month intervals, respectively, following completion of first anthracycline therapy."}

    PubmedHPO

    {"project":"PubmedHPO","denotations":[{"id":"T5","span":{"begin":0,"end":15},"obj":"HP_0001635"}],"text":"Cardiac failure occurred progressively after 31-month, 32-month, and 14-month intervals, respectively, following completion of first anthracycline therapy."}